Alexandra E Johns - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alexandra E Johns

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Stem Cells (Dayton, Ohio)|May 5, 2022

Exploring Motor Neuron Diseases Using iPSC PlatformsAlexandra E Johns, Nicholas J Maragakis

Stem Cells Translational Medicine|October 17, 2024

Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron modelAlexandra E Johns, Arens Taga, Andriana Charalampopoulou, et al.

ACS Medicinal Chemistry Letters|January 16, 2020

Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid LeukemiaAndrew E Shouksmith, Justyna M Gawel, Nabanita Nawar, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Stem Cells (Dayton, Ohio)|May 5, 2022

Exploring Motor Neuron Diseases Using iPSC PlatformsAlexandra E Johns, Nicholas J Maragakis

Stem Cells Translational Medicine|October 17, 2024

Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron modelAlexandra E Johns, Arens Taga, Andriana Charalampopoulou, et al.

ACS Medicinal Chemistry Letters|January 16, 2020

Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid LeukemiaAndrew E Shouksmith, Justyna M Gawel, Nabanita Nawar, et al.

Pageof 1